Clear Investment Research »

Alnylam Pharmaceuticals shares owned by Clear Investment Research

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Clear Investment Research from 13F filings

Historical chart of Clear Investment Research investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Clear Investment Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Clear Investment Research

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9k 7 275.00

More positions owned by Clear Investment Research

Ishares Tr Core S&p500 Etf (IVV)
Vanguard World Extended Dur (EDV)
Graphic Packaging Holding Company (GPK)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Apple (AAPL)
Ishares Tr Cores Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Scwab Strategic Tr Us Lrg Cap Etf (SCHX)
Eli Lilly & Co. (LLY)
Scwab Strategic Tr Sht Tm Us Tres (SCHO)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Vaneck Vectors Etf Tr Fallen Angel Hg (ANGL)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Clear Investment Research

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals